Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1358 (Faslodex, Fulvestrant, ICI 182,780, ICI-182780, NSC-759879, ZD9238, ZD-9238) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Bacterial beta-lactamase TEM in Bacteria (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2364670] [UniProtKB: P62593] | ||||||||
ChEMBL | Inhibition of bacterial wild type Beta-lactamase TEM-1 pre-incubated for 5 mins before addition of chromogenic beta-lactamase substrate CENTA by spectrophotometry | B | 4.25 | pIC50 | 55900 | nM | IC50 | J Med Chem (2019) 62: 9593-9599 [PMID:31589047] |
Farnesoid X receptor/Bile acid receptor FXR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2047] [GtoPdb: 603] [UniProtKB: Q96RI1] | ||||||||
ChEMBL | Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay | B | 6.1 | pIC50 | 790 | nM | IC50 | Bioorg Med Chem (2013) 21: 4266-4278 [PMID:23688559] |
epoxide hydrolase 2/Epoxide hydratase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2409] [GtoPdb: 2970] [UniProtKB: P34913] | ||||||||
ChEMBL | Competitive inhibition of human recombinant soluble epoxide hydrolase using [3H]-tDPPO as substrate | B | 7.59 | pKi | 26 | nM | Ki | Bioorg Med Chem Lett (2013) 23: 3818-3821 [PMID:23684894] |
ChEMBL | Inhibition of human recombinant soluble epoxide hydrolase using (cyano(6-methoxy-naphthelen-2-yl)methyl trans-[(3-phenyl-oxiran-2-yl)methyl] carbonate) as substrate preincubated for 5 mins prior to substrate addition by fluorescence assay | B | 8.22 | pIC50 | 6 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 3818-3821 [PMID:23684894] |
Estrogen receptor-α/Estrogen receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL206] [GtoPdb: 620] [UniProtKB: P03372] | ||||||||
ChEMBL | Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by measuring dissociation constant for degradation by luciferase reporter gene assay relative to untreated control | B | 8.33 | pKd | 4.69 | nM | Kd | Bioorg Med Chem (2019) 27: 1952-1961 [PMID:30940565] |
GtoPdb | - | - | 8.98 | pKi | 1.04 | nM | Ki | J Med Chem (2003) 46: 1408-18 [PMID:12672240] |
ChEMBL | In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor alpha | B | 8.98 | pKi | 1.04 | nM | Ki | J Med Chem (2003) 46: 1408-1418 [PMID:12672240] |
ChEMBL | Displacement of fluorescent estradiol from full-length ERalpha (unknown origin) measured after 2 hrs by fluorescence polarization assay | B | 7.05 | pIC50 | 88.5 | nM | IC50 | Eur J Med Chem (2021) 226: 113870-113870 [PMID:34610548] |
ChEMBL | Displacement of [3H]-E2 from estrogen receptor-alpha (unknown origin) by scintillation counting analysis | B | 7.62 | pIC50 | 24 | nM | IC50 | J Med Chem (2015) 58: 4888-4904 [PMID:25879485] |
ChEMBL | Downregulation of ER-alpha expression in human T47D cells measured after 5 days by Western blot analysis | B | 8.03 | pIC50 | 9.3 | nM | IC50 | J Med Chem (2016) 59: 8134-8140 [PMID:27529700] |
ChEMBL | Downregulation of ER-alpha expression in human tamoxifen-resistant T47D cells over-expressing PKC-alpha measured after 5 days by Western blot analysis | B | 8.07 | pIC50 | 8.5 | nM | IC50 | J Med Chem (2016) 59: 8134-8140 [PMID:27529700] |
ChEMBL | Displacement of [3H]17-beta-estradiol from human Estrogen receptor alpha | B | 8.22 | pIC50 | 6 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 147-151 [PMID:10673099] |
ChEMBL | Antagonist activity at ERalpha in human MCF7 cells assessed as inhibition of estradiol-driven cell growth measured after 7 days by SYTOX green-based assay | B | 8.3 | pIC50 | 5.01 | nM | IC50 | J Med Chem (2019) 62: 1593-1608 [PMID:30640465] |
ChEMBL | Binding affinity to human ERalpha | B | 8.31 | pIC50 | 4.9 | nM | IC50 | J Med Chem (2007) 50: 4471-4481 [PMID:17696335] |
ChEMBL | Antagonist activity at estrogen receptor alpha ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay | B | 8.4 | pIC50 | 4 | nM | IC50 | J Nat Prod (2009) 72: 1944-1948 [PMID:19863083] |
ChEMBL | Induction of selective estrogen receptor alpha degradation in human MCF7 cells harboring TK-ERE-Luc assessed as reduction in estradiol-induced GREB1 mRNA expression after 24 hrs by TaqMan assay | B | 8.42 | pIC50 | 3.8 | nM | IC50 | J Med Chem (2018) 61: 2837-2864 [PMID:29562737] |
ChEMBL | Antagonist activity at ERalpha in human MCF7 cells assessed as inhibition of estrogen-induced transcription preincubated overnight followed by estrogen addition measured after 24 hrs by dual luciferase reporter gene assay | B | 8.47 | pIC50 | 3.4 | nM | IC50 | J Med Chem (2017) 60: 2790-2818 [PMID:28296398] |
ChEMBL | Induction of selective estrogen receptor alpha degradation in human MCF7 cells harboring TK-ERE-Luc assessed as reduction in estradiol-induced transcriptional activity after 24 hrs by luciferase reporter gene assay | B | 8.47 | pIC50 | 3.4 | nM | IC50 | J Med Chem (2018) 61: 2837-2864 [PMID:29562737] |
ChEMBL | Displacement of fluoromone ligand from recombinant ER-alpha (unknown origin) by LanthaScreen TR-FRET assay | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2016) 59: 8134-8140 [PMID:27529700] |
ChEMBL | Displacement of fluorescent-labeled E2 from LBD of ERalpha (unknown origin) by TR-FRET assay | B | 8.55 | pIC50 | 2.85 | nM | IC50 | J Med Chem (2021) 64: 5766-5786 [PMID:33904307] |
ChEMBL | Displacement of fluorescent-labelled E2 from recombinant human GST-tagged ERalpha by LanthaScreen TR-FRET assay | B | 8.55 | pIC50 | 2.85 | nM | IC50 | Eur J Med Chem (2020) 192: 112191-112191 [PMID:32169784] |
ChEMBL | Inhibition of ERalpha in human MCF7:WS8 cells assessed as increase in degradation of ERalpha incubated for 24 hrs by In-Cell Western assay | B | 8.8 | pIC50 | 1.58 | nM | IC50 | J Med Chem (2019) 62: 11301-11323 [PMID:31746603] |
ChEMBL | Induction of ERalpha degradation in human MCF7 cells after 18 hrs by Western blot analysis | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2017) 60: 2790-2818 [PMID:28296398] |
ChEMBL | Induction of selective estrogen receptor alpha degradation in human MCF7 cells after 18 to 24 hrs by in-cell Western analysis | B | 8.92 | pIC50 | 1.2 | nM | IC50 | J Med Chem (2018) 61: 2837-2864 [PMID:29562737] |
ChEMBL | Induction of ERalpha degradation in human MCF7 cells after 18 to 24 hrs by Western blot analysis | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2017) 60: 2790-2818 [PMID:28296398] |
ChEMBL | Induction of ERalpha degradation in human T47D cells | B | 9.08 | pIC50 | 0.84 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1342-1347 [PMID:32551022] |
ChEMBL | Binding affinity to ERalpha receptor (unknown origin) | B | 9.09 | pIC50 | 0.81 | nM | IC50 | J Med Chem (2015) 58: 8128-8140 [PMID:26407012] |
ChEMBL | Antagonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as reduction in E2-induced ER-alpha-mediated transcriptional activity by luciferase reporter gene assay | B | 9.11 | pIC50 | 0.78 | nM | IC50 | Bioorg Med Chem (2019) 27: 1952-1961 [PMID:30940565] |
ChEMBL | Antagonist effect on transcriptional activation in MCF-7 cells expressing estrogen receptor alpha | F | 9.33 | pIC50 | 0.47 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 147-151 [PMID:10673099] |
ChEMBL | Induction of ERalpha degradation in human MCF7 cells after 4 hrs by FITC/Hoechst staining based immunofluorescence imaging analysis | B | 9.49 | pIC50 | 0.32 | nM | IC50 | ACS Med Chem Lett (2020) 11: 1342-1347 [PMID:32551022] |
ChEMBL | Downregulation of human ERalpha in human MCF-7 cells after 24 hrs by in-cell Western immunoassay method | B | 9.52 | pIC50 | 0.3 | nM | IC50 | J Med Chem (2017) 60: 6321-6336 [PMID:28657320] |
ChEMBL | Antagonist activity at estrogen receptor in human T47D cells incubated for 18 hrs by ultra high sensitivity luminescence reporter gene assay | B | 9.6 | pIC50 | 0.25 | nM | IC50 | J Med Chem (2021) 64: 11841-11856 [PMID:34251202] |
ChEMBL | Antagonist activity at ERalpha receptor in human MCF7 cells | B | 10.2 | pIC50 | 0.06 | nM | IC50 | J Med Chem (2015) 58: 8128-8140 [PMID:26407012] |
ChEMBL | Induction of ERalpha degradation in human MCF7 cells assessed as inhibition of insulin-mediated cell proliferation after 6 days by Hoechst 33258 dye-based assay | B | 10.22 | pIC50 | 0.06 | nM | IC50 | J Med Chem (2017) 60: 2790-2818 [PMID:28296398] |
ChEMBL | Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay | B | 8.85 | pEC50 | 1.4 | nM | EC50 | Bioorg Med Chem (2019) 27: 1952-1961 [PMID:30940565] |
ChEMBL | Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assay | B | 9.4 | pEC50 | 0.4 | nM | EC50 | J Med Chem (2015) 58: 4888-4904 [PMID:25879485] |
ChEMBL | Induction of ERalpha degradation in human MCF7 cells in phenol red free RPMI medium containing 5% charcoal-stripped FBS incubated for 4 hrs by IRDye 800CW/DRAQ5 dye based in-cell Western assay | B | 9.4 | pEC50 | 0.4 | nM | EC50 | Bioorg Med Chem Lett (2019) 29: 367-372 [PMID:30587451] |
Estrogen receptor-α/Estrogen receptor alpha in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2724] [GtoPdb: 620] [UniProtKB: P06211] | ||||||||
ChEMBL | Displacement of [3H]estradiol from rat uterine cytosolic estrogen receptor | B | 8.23 | pIC50 | 5.89 | nM | IC50 | Bioorg Med Chem (2012) 20: 2353-2361 [PMID:22377671] |
Estrogen receptor-β/Estrogen receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL242] [GtoPdb: 621] [UniProtKB: Q92731] | ||||||||
ChEMBL | In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor beta | B | 8.86 | pKi | 1.39 | nM | Ki | J Med Chem (2003) 46: 1408-1418 [PMID:12672240] |
GtoPdb | - | - | 8.86 | pKi | 1.39 | nM | Ki | J Med Chem (2003) 46: 1408-18 [PMID:12672240] |
ChEMBL | Binding affinity to human ERbeta | B | 7.36 | pIC50 | 44.1 | nM | IC50 | J Med Chem (2007) 50: 4471-4481 [PMID:17696335] |
ChEMBL | Displacement of [3H]-E2 from estrogen receptor-beta (unknown origin) by scintillation counting analysis | B | 7.68 | pIC50 | 21 | nM | IC50 | J Med Chem (2015) 58: 4888-4904 [PMID:25879485] |
ChEMBL | Displacement of fluorescent-labeled E2 from LBD of ERbeta (unknown origin) by TR-FRET assay | B | 7.99 | pIC50 | 10.2 | nM | IC50 | J Med Chem (2021) 64: 5766-5786 [PMID:33904307] |
ChEMBL | Displacement of fluorescent-labelled E2 from recombinant human GST-tagged ERbeta by LanthaScreen TR-FRET assay | B | 7.99 | pIC50 | 10.2 | nM | IC50 | Eur J Med Chem (2020) 192: 112191-112191 [PMID:32169784] |
ChEMBL | Inhibition of human estrogen receptor 2 using tritiated estradiol incubated for 3 hr | B | 8.08 | pIC50 | 8.4 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 3912-3916 [PMID:15993065] |
ChEMBL | Displacement of [3H]17-beta-estradiol from human Estrogen receptor beta | B | 8.15 | pIC50 | 7 | nM | IC50 | Bioorg Med Chem Lett (2000) 10: 147-151 [PMID:10673099] |
ChEMBL | Antagonist activity at estrogen receptor beta ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay | B | 8.42 | pIC50 | 3.8 | nM | IC50 | J Nat Prod (2009) 72: 1944-1948 [PMID:19863083] |
Estrogen-related receptor-α/Estrogen-related receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3429] [GtoPdb: 622] [UniProtKB: P11474] | ||||||||
ChEMBL | Antagonist activity at ERalpha receptor in human MCF7 cells assessed as inhibition of cell growth after 6 days by crystal violet staining method | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2013) 56: 2779-2790 [PMID:23448346] |
sirtuin 5/NAD-dependent protein deacylase sirtuin-5, mitochondrial in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2163183] [GtoPdb: 2711] [UniProtKB: Q9NXA8] | ||||||||
ChEMBL | Inhibition of SIRT5 (unknown origin) | B | 5.59 | pIC50 | 2600 | nM | IC50 | Eur J Med Chem (2020) 206: 112676-112676 [PMID:32858418] |
Pregnane X receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3401] [GtoPdb: 606] [UniProtKB: O75469] | ||||||||
ChEMBL | Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay | B | 5.71 | pEC50 | 1950 | nM | EC50 | Bioorg Med Chem (2013) 21: 4266-4278 [PMID:23688559] |
Progesterone receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL208] [GtoPdb: 627] [UniProtKB: P06401] | ||||||||
ChEMBL | Agonist activity at progesterone receptor in human MCF7 cells | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2015) 58: 8128-8140 [PMID:26407012] |
ChEMBL | Antagonist activity at progesterone receptor in human MCF cells assessed as estradiol-induced receptor response | B | 9.68 | pIC50 | 0.21 | nM | IC50 | J Med Chem (2015) 58: 8128-8140 [PMID:26407012] |
GPER in Human [GtoPdb: 221] [UniProtKB: Q99527] | ||||||||
GtoPdb | - | - | 7 | pKi | - | - | - | Endocrinology (2005) 146: 624-32 [PMID:15539556] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]